Enrollment Status: Open
The study will be investigating a specific bNAb named SAR441236, an antibod that has been manfuctured to attach to three parts of the HIV virus at the same time and to block the ability of the virus to infect more cells.
This study will determine if one infusion of SAR441236 is safe and tolerable, and will measure the amount of SAR441236 in the blood over time. The study will see if SAR441236 can reduce the amount of HIV in a person’s blood. Increasing dose levels and multiple infusions will be studied.